According to WHO, the drug nOPV2, used orally, is characterized by high genetic stability and effectiveness compared to existing alternatives, which reduces the risk of new epidemics.
The use of the new vaccine creates an opportunity for many countries to become polio-free territories.
Polio is an acute viral disease affecting the nervous system, primarily the spinal cord. The highest risk group is children under five years of age. In some cases, the disease can lead to paralysis and death.
